Logo image of FAMI

FARMMI INC (FAMI) Stock Fundamental Analysis

NASDAQ:FAMI - Nasdaq - KYG332771495 - Common Stock - Currency: USD

1.81  -0.04 (-2.16%)

After market: 1.7908 -0.02 (-1.06%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to FAMI. FAMI was compared to 91 industry peers in the Food Products industry. FAMI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. FAMI does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year FAMI has reported negative net income.
In the past year FAMI has reported a negative cash flow from operations.
Of the past 5 years FAMI 4 years were profitable.
FAMI had negative operating cash flow in 4 of the past 5 years.
FAMI Yearly Net Income VS EBIT VS OCF VS FCFFAMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M -40M -60M

1.2 Ratios

Looking at the Return On Assets, with a value of -2.49%, FAMI is doing worse than 65.93% of the companies in the same industry.
FAMI has a Return On Equity of -2.74%. This is in the lower half of the industry: FAMI underperforms 64.84% of its industry peers.
With a Return On Invested Capital value of 0.39%, FAMI is not doing good in the industry: 63.74% of the companies in the same industry are doing better.
FAMI had an Average Return On Invested Capital over the past 3 years of 0.66%. This is significantly below the industry average of 28.19%.
Industry RankSector Rank
ROA -2.49%
ROE -2.74%
ROIC 0.39%
ROA(3y)0.11%
ROA(5y)0.78%
ROE(3y)0.09%
ROE(5y)0.93%
ROIC(3y)0.66%
ROIC(5y)1.86%
FAMI Yearly ROA, ROE, ROICFAMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

FAMI has a Operating Margin of 1.24%. This is comparable to the rest of the industry: FAMI outperforms 42.86% of its industry peers.
In the last couple of years the Operating Margin of FAMI has declined.
FAMI's Gross Margin of 6.04% is on the low side compared to the rest of the industry. FAMI is outperformed by 84.62% of its industry peers.
In the last couple of years the Gross Margin of FAMI has declined.
Industry RankSector Rank
OM 1.24%
PM (TTM) N/A
GM 6.04%
OM growth 3Y-44.49%
OM growth 5Y-34.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.56%
GM growth 5Y-19.38%
FAMI Yearly Profit, Operating, Gross MarginsFAMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 15

More info and screens

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), FAMI is destroying value.
Compared to 1 year ago, FAMI has more shares outstanding
Compared to 5 years ago, FAMI has more shares outstanding
The debt/assets ratio for FAMI has been reduced compared to a year ago.
FAMI Yearly Shares OutstandingFAMI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
FAMI Yearly Total Debt VS Total AssetsFAMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

Based on the Altman-Z score of 1.52, we must say that FAMI is in the distress zone and has some risk of bankruptcy.
FAMI's Altman-Z score of 1.52 is in line compared to the rest of the industry. FAMI outperforms 40.66% of its industry peers.
A Debt/Equity ratio of 0.04 indicates that FAMI is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.04, FAMI is doing good in the industry, outperforming 75.82% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 1.52
ROIC/WACC0.11
WACC3.4%
FAMI Yearly LT Debt VS Equity VS FCFFAMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M

2.3 Liquidity

FAMI has a Current Ratio of 16.10. This indicates that FAMI is financially healthy and has no problem in meeting its short term obligations.
FAMI's Current ratio of 16.10 is amongst the best of the industry. FAMI outperforms 98.90% of its industry peers.
A Quick Ratio of 15.55 indicates that FAMI has no problem at all paying its short term obligations.
FAMI has a better Quick ratio (15.55) than 98.90% of its industry peers.
Industry RankSector Rank
Current Ratio 16.1
Quick Ratio 15.55
FAMI Yearly Current Assets VS Current LiabilitesFAMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

1

3. Growth

3.1 Past

The earnings per share for FAMI have decreased strongly by -251.68% in the last year.
Looking at the last year, FAMI shows a very negative growth in Revenue. The Revenue has decreased by -41.89% in the last year.
The Revenue has been growing by 17.50% on average over the past years. This is quite good.
EPS 1Y (TTM)-251.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-949.2%
Revenue 1Y (TTM)-41.89%
Revenue growth 3Y17.74%
Revenue growth 5Y17.5%
Sales Q2Q%-44.42%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FAMI Yearly Revenue VS EstimatesFAMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

FAMI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FAMI Price Earnings VS Forward Price EarningsFAMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of FAMI indicates a rather cheap valuation: FAMI is cheaper than 85.71% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 5.21
FAMI Per share dataFAMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FAMI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FARMMI INC

NASDAQ:FAMI (7/28/2025, 8:25:59 PM)

After market: 1.7908 -0.02 (-1.06%)

1.81

-0.04 (-2.16%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-22 2022-08-22/bmo
Earnings (Next)N/A N/A
Inst Owners1.13%
Inst Owner Change0%
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap2.26M
Analysts0
Price TargetN/A
Short Float %3.2%
Short Ratio0.88
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.04
P/FCF N/A
P/OCF N/A
P/B 0.01
P/tB 0.01
EV/EBITDA 5.21
EPS(TTM)-7.48
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-13.44
FCFYN/A
OCF(TTM)-13.42
OCFYN/A
SpS51.31
BVpS135.99
TBVpS135.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.49%
ROE -2.74%
ROCE 0.45%
ROIC 0.39%
ROICexc 0.39%
ROICexgc 0.39%
OM 1.24%
PM (TTM) N/A
GM 6.04%
FCFM N/A
ROA(3y)0.11%
ROA(5y)0.78%
ROE(3y)0.09%
ROE(5y)0.93%
ROIC(3y)0.66%
ROIC(5y)1.86%
ROICexc(3y)0.75%
ROICexc(5y)2.1%
ROICexgc(3y)0.75%
ROICexgc(5y)2.11%
ROCE(3y)0.77%
ROCE(5y)2.34%
ROICexcg growth 3Y-45.62%
ROICexcg growth 5Y-47.84%
ROICexc growth 3Y-45.62%
ROICexc growth 5Y-47.84%
OM growth 3Y-44.49%
OM growth 5Y-34.82%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-22.56%
GM growth 5Y-19.38%
F-Score2
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA 9.21
Cap/Depr 265.77%
Cap/Sales 0.05%
Interest Coverage 12.13
Cash Conversion N/A
Profit Quality N/A
Current Ratio 16.1
Quick Ratio 15.55
Altman-Z 1.52
F-Score2
WACC3.4%
ROIC/WACC0.11
Cap/Depr(3y)88.96%
Cap/Depr(5y)118.73%
Cap/Sales(3y)0.02%
Cap/Sales(5y)0.19%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-251.68%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-949.2%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-41.89%
Revenue growth 3Y17.74%
Revenue growth 5Y17.5%
Sales Q2Q%-44.42%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-61.17%
EBIT growth 3Y-34.64%
EBIT growth 5Y-23.41%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y77.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y77.86%
OCF growth 3YN/A
OCF growth 5YN/A